Concepedia

Rachel‐Ann A. Garibsingh

RA

Statistics

Publications

5

Citations

180

H-Index

5

Active since

2016

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Binghamton University

Rachel‐Ann A. Garibsingh is an author at Icahn School of Medicine at Mount Sinai specializing in structural biology, medicine, and bioinformatics.

ORCID

Top concepts

Publications per year

2016–2023

5

Publications

5

Rational design of ASCT2 inhibitors using an integrated experimental-computational approach

Rachel‐Ann A. Garibsingh, Elias Ndaru, Alisa A. Garaeva et al. · Proceedings of the National Academy of Sciences · 2021 · 61 citations · Full text

Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations

Albino Troilo, Erica K. Benson, Davide Esposito et al. · Oncotarget · 2016 · 50 citations · Full text

Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds

Elias Ndaru, Rachel‐Ann A. Garibsingh, Yueyue Shi et al. · The Journal of General Physiology · 2019 · 30 citations · Full text

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2

Rachel‐Ann A. Garibsingh, Nicholas Otte, Elias Ndaru et al. · Frontiers in Chemistry · 2018 · 23 citations · Full text

, , +18

Conserved allosteric inhibition mechanism in SLC1 transporters

Dong Yang, Jiali Wang, Rachel‐Ann A. Garibsingh et al. · eLife · 2023 · 16 citations · Full text

1–5 of 5